Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT05082480
Other study ID # RDCT-TWDH
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date May 5, 2022
Est. completion date April 28, 2023

Study information

Verified date May 2022
Source SciVision Biotech Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To Evaluate the Effectiveness of the use of a Novel Crosslinking Hyaluronan Hydrogel on the Prevention of the Adhesion Occurrence After Trigger Finger Release Surgery


Description:

The medical device is a bioabsorbable, extensible, crosslinked, 6% hyaluronic acid gel using fermentation sourced hyaluronic acid as a major component. This product could perfectly attach to the tissue surface, creating anti-adhesion layer which avoids post-surgical adhesion and is completely resorbed over time. This study is aimed to evaluate the effectiveness of the use of a novel crosslinking hyaluronan hydrogel on the prevention of the adhesion occurrence after trigger finger release surgery.


Recruitment information / eligibility

Status Terminated
Enrollment 5
Est. completion date April 28, 2023
Est. primary completion date April 28, 2023
Accepts healthy volunteers No
Gender All
Age group 20 Years to 65 Years
Eligibility Inclusion Criteria: 1. Agree to participate in this study and sign informed consent form 2. Age 20 to 65 years of male or female 3. The trigger finger, except thumb, classified as 3 to 4 points and plan to conduct trigger finger release surgery; 4. The trigger finger, except thumb, classified as 2 points with the symptom of flexion contracture and plan to conduct trigger finger release surgery; 5. Agree to comply with the follow-up schedule of this study Exclusion Criteria: 1. Target finger has other adhesion in tendon, joint, or proximal nerve, neuropathy, compression injury or other disease; 2. Other fingers in the same hand as the target finger have other adhesion in tendon, joint, or proximal nerve, neuropathy, or compression injury; 3. Contralateral finger has other adhesion in tendon, joint, or proximal nerve, neuropathy, or compression injury; 4. The operation site was conducted tendon transplantation or any surgery in past 6 months; 5. Receiving orthopedic-related treatment which may affect the evaluation of the study; 6. The skin of the operation site with infection, deficiency, or needing skin transplantation; 7. With poorly controlled chronic diseases, such as diabetes mellitus; 8. Patient with autoimmune disease (such as rheumatoid arthritis), malignant tumors, coagulation diseases, heart diseases, mental diseases, etc., may cause patients to participate in the trial at higher risk; 9. Patient who has taken cortisol within the past 6 months, systemic corticosteroids within the past 2 months, immunosuppressive drugs within past 3 months, or non-steroidal anti-inflammatory drugs (NSAIDs) everyday within 1 week or NSAIDs within 8 hours occasionally. (subjects who have received inhaled/intranasal corticosteroids could be considered to include.); 10. With clinical meaningful coagulation disorders, underdoing anticoagulant treatment or taking blood circulation promotion and blood stasis removement medications within the past 10 days; 11. With history of hypersensitivity or allergy to hyaluronic acid or any component of the device; With history of hypersensitivity or allergy to Gram-positive bacteria or Streptococcus proteins; other severe hypersensitivity history unsuitable for participating in the study; 12. Pregnant, planning pregnancy or in breastfeeding females; 13. Other circumstances which judged to be unsuitable for participating in the study by the investigator.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Hyaluronic acid (HA)
Hyaluronic acid (HA)
Saline
Saline

Locations

Country Name City State
Taiwan Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung
Taiwan Kaohsiung Municipal Ta-Tung Hospital Kaohsiung

Sponsors (1)

Lead Sponsor Collaborator
SciVision Biotech Inc.

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary The percentage of Total Active Motion (TAM) score for target finger. The percentage of Total Active Motion (TAM) score for target finger at 30 days post-operation. 30 days post-operation
Secondary The percentage of TAM score of target finger. The percentage of TAM score of target finger at baseline, 14, 60, 90, and 180 days post-operation. baseline, 14, 60, 90, and 180 days post-operation
Secondary TAM score of target finger. TAM score of target finger at baseline, 14, 30, 60, 90, and 180 days post-operation. baseline, 14, 30, 60, 90, and 180 days post-operation
Secondary The grade of TAM score of target finger and contralateral finger. The grade of TAM score of target finger and contralateral finger at baseline, 14, 30, 60, 90, and 180 days post-operation baseline, 14, 30, 60, 90, and 180 days post-operation
Secondary Subjects self-evaluating Visual Analogue Scale (VAS) in pain of target finger at baseline, 14, 30, 60, 90, and 180 days post-operation. Subjects self-evaluating Visual Analogue Scale (VAS) in pain of target finger at baseline, 14, 30, 60, 90, and 180 days post-operation. The VAS scale uses a 100 mm line labelled at '0' with 'no pain' and '100' with 'worst pain' baseline, 14, 30, 60, 90, and 180 days post-operation
Secondary Subjects self-evaluating Quick Disabilities of the Arm, Shoulder and Hand Score (Quick-Dash). Subjects self-evaluating Quick Disabilities of the Arm, Shoulder and Hand Score (Quick-Dash) at baseline, 14, 30, 60, 90, and 180 days post-operation. baseline, 14, 30, 60, 90, and 180 days post-operation
Secondary The evaluation of tendon by sonography. The evaluation of tendon by sonography at baseline, 14, 30, 60, 90, and 180 days post-operation. baseline, 14, 30, 60, 90, and 180 days post-operation
Secondary Subjects self-evaluating Visual Analogue Scale (VAS) in satisfaction Subjects self-evaluating satisfaction at 14, 30, 60, 90, and 180 days post-operation. Patients rate their treatment satisfaction based on a 100 mm VAS. The VAS scale uses a 100 mm line labelled at '0' with 'least satisfaction' and '100' with 'highest satisfaction'. 14, 30, 60, 90, and 180 days post-operation
Secondary The incidence, severity and correlation of adverse event (AE) and serious adverse event (SAE). The incidence, severity and correlation of adverse event (AE) and serious adverse event (SAE). baseline, 14, 30, 60, 90, and 180 days post-operation
See also
  Status Clinical Trial Phase
Completed NCT04094389 - Comparison of Trigger Finger Orthotic Wearing Schedules N/A
Completed NCT05435950 - Clinical Investigation on Safety, Performance and Effectiveness of Sono-instruments N/A
Completed NCT04900220 - Differences in Flare Reaction Incidence and Intensity Following Trigger Finger Injections Phase 4
Completed NCT06401473 - Using the Gate Control Theory of Pain to Decrease Pain During Trigger Finger Corticosteroid Injections N/A
Completed NCT04354415 - Tourniquet vs. No Tourniquet for Carpal Tunnel and Trigger Finger Release N/A
Recruiting NCT06296017 - Effectiveness of Conservative Interventions in the Treatment of Trigger Finger N/A
Completed NCT06288685 - Percutaneous Trigger Finger Release Concomitant Steroid Injection Versus Percutaneous Trigger Finger Release Alone Phase 3
Completed NCT06382623 - Efficacies of Different Managements in Patients With Trigger Finger
Active, not recruiting NCT04568993 - The TriggerHappy Trial N/A
Completed NCT04023695 - Trigger Finger Corticosteroid Injection With and Without Local Anesthetic Phase 4
Recruiting NCT04645303 - Injection of Hyaluronic Acid Versus Corticosteroid for Treatment of Trigger Finger Early Phase 1
Recruiting NCT03156829 - Effectiveness of Cortisone Injection and Splinting for Trigger Finger Phase 4
Completed NCT01987115 - Comparison of Fascial Manipulation With Traditional Physiotherapy for the Treatment of Trigger Fingers N/A
Completed NCT01950793 - A Comparison Between Sonoguided Injection Corticosteroid and Hyaluronic Acid Injection in Treatment of Trigger Finger N/A
Completed NCT02196233 - Surgical Treatment of Adult Trigger Finger
Recruiting NCT04675892 - Resection of Flexor Digitorum Superficialis Tendon for Severe Trigger Fingers N/A
Recruiting NCT05045157 - Effectiveness of Percutaneous Pulley Release With Infiltration, Versus Infiltration Alone in Trigger Finders N/A
Active, not recruiting NCT01886157 - Treatment of Trigger Finger With Steroid Injection Versus Steroid Injection and Splinting N/A
Recruiting NCT00951236 - Study Comparing One Versus Two Cortisone Injections for Trigger Finger N/A
Withdrawn NCT04855942 - Focused Extracorporeal Shock Wave Therapy (ESWT) Versus Traditional Physiotherapy in the Treatment of Trigger Finger N/A